Market Overview

The Carmustine market is predicted to develop at a compound annual growth rate (CAGR) of 2.84% from 2024 to 2034, when it is projected to reach USD 1.03 Billion, based on an average growth pattern. The market is estimated to reach a value of USD 0.78 Billion in 2024.

SOURCE: We Market Research

Filgrastim, a colony-stimulating factor drug, increases white blood cell production in the bone marrow, particularly neutrophils. Neutrophils, which are essential for fighting infections, can decrease during chemotherapy, resulting in neutropenia. Filgrastim is critical in lowering infection risks in these patients by increasing neutrophil counts. It has applications in a variety of settings, including bone marrow transplants, some malignancies, and myelodysplastic syndrome, where neutropenia is a concern. Filgrastim, which is administered via subcutaneous injection or intravenous infusion, is marketed under the names Neupogen, Zarxio, Grastofil, and Nivestim, and it provides a lifeline to people who have reduced immune function.

Numerous reasons are driving the worldwide filgrastim market. Growing cancer rates increase the need for filgrastim, which is essential for treating neutropenia brought on by chemotherapy. Market growth is supported by its expanding uses, which include treating illnesses like myelodysplastic syndrome. Enhancing accessibility is made possible by better healthcare infrastructure, particularly in rising economies. Demand is further increased as the population ages and more disorders that need Filgrastim become prevalent. The market reach of Filgrastim is increased by raising awareness of the dangers of neutropenia and its function. Strategic partnerships, technical advancements, supportive legislative frameworks, and healthcare reforms all make major contributions. Furthermore, the patent expiration of branded items increases accessibility and competition, which drives further market growth.

Market Scope

Carmustine Industry: Dynamics & Restrains

We Market Research: Carmustine Dashboard

Our marketing platform offers a comprehensive dashboard that provides clients with valuable insights into market trends over the years. Included below is a sample image of our dashboard, and specific PDF logins will be furnished to grant access to this insightful tool.

Carmustine Segmentation

Market- By Type Analysis

By Type, the Carmustine Market is Categories into Granulocyte-Colony Stimulating Factor (G-CSF), Long-acting Filgrastim (pegfilgrastim). The Long-acting Filgrastim (pegfilgrastim) segment accounts for the largest share of around 76% in 2024.

Long-acting Filgrastim (pegfilgrastim) is driven by its extended dosing intervals, reducing the frequency of injections compared to standard Filgrastim. This offers convenience to patients undergoing chemotherapy, improving compliance and potentially reducing healthcare costs associated with treatment administration.

The following segments are part of an in-depth analysis of the global Carmustine market:

Carmustine Industry: Regional Analysis

North America Market Forecast

North America dominate the Carmustine Market with the highest revenue generating market with share of more than 47%. North America's Carmustine market is driven by a high cancer prevalence, technological advancements and high healthcare expenditure in countries like the United States and Canada are propelling the growth of the filgrastim market. Also the prevalence of cancer and other chronic diseases in this region drives the demand for filgrastim-based treatments.

Europe Market Statistics

Europe's Carmustine market benefits from the rising incidence of cancer in Europe increases demand for Carmustine. In Europe, witnessing an increasing demand for biosimilars, including filgrastim, due to patent expirations of branded drugs. Government initiatives promoting the use of biosimilars to reduce healthcare costs and the presence of established pharmaceutical companies focusing on biosimilar production are driving the market in this region.

Asia Pacific Market Forecasts

Asia Pacific is expected to be the fastest-growing regional segment of the Carmustine market during the forecast period. In the Asia Pacific, the Filgrastim market thrives due to increasing cancer cases, rising healthcare spending, supportive government policies, a growing elderly population, biotechnological advancements, and extensive clinical research, collectively propelling demand for this vital drug.

Key Market Players

The Filgrastim Market is dominated by a few large companies, such as

·         Amgen

·         SANDOZ INC

·         Teva Pharmaceutical

·         Others

1.      Global Carmustine Market Introduction and Market Overview

1.1.    Objectives of the Study

1.2.    Global Carmustine Market Scope and Market Estimation

1.2.1. Global Carmustine Overall Market Size, Revenue (US$ Mn), Market CAGR (%), Market forecast (2023 - 2034)

1.2.2. Global Carmustine Market Revenue Share (%) and Growth Rate (Y-o-Y) from 2019 - 2034

1.3.    Market Segmentation

1.3.1. Product Type of Global Carmustine Market

1.3.2. Application of Global Carmustine Market

1.3.3. Distribution Channel of Global Carmustine Market

1.3.4. Region of Global Carmustine Market

2.      Executive Summary

2.1.    Global Carmustine Market Industry Trends under COVID-19 Outbreak

2.1.1. Global COVID-19 Status Overview

2.1.2. Influence of COVID-19 Outbreak on Global Carmustine Market Industry Development

2.2.    Market Dynamics

2.2.1. Drivers

2.2.2. Limitations

2.2.3. Opportunities

2.2.4. Impact Analysis of Drivers and Restraints

2.3.    Pricing Trends Analysis & Average Selling Prices (ASPs)

2.4.    Key Mergers & Acquisitions, Expansions, JVs, Funding / VCs, etc.

2.5.    Porter’s Five Forces Analysis

2.5.1. Bargaining Power of Suppliers

2.5.2. Bargaining Power of Buyers

2.5.3. Threat of Substitutes

2.5.4. Threat of New Entrants

2.5.5. Competitive Rivalry

2.6.      Market Investment Opportunity Analysis (Top Investment Pockets), By Segments & By Region

3.      Global Carmustine Market Estimates & Historical Trend Analysis (2019 - 2023)

4.      Global Carmustine Market Estimates & Forecast Trend Analysis, by Product Type

4.1.    Global Carmustine Market Revenue (US$ Mn) Estimates and Forecasts, by Product Type, 2019 to 2034

4.1.1. Carmustine for Injection

4.1.2. Implantable Carmustine Wafer

5.      Global Carmustine Market Estimates & Forecast Trend Analysis, by Application

5.1.    Global Carmustine Market Revenue (US$ Mn) Estimates and Forecasts, by Application, 2019 to 2034

5.1.1. Brain Cancer

5.1.2. Multiple Myeloma

5.1.3. Hodgkin's Lymphoma

5.1.4. Non-Hodgkin's Lymphoma

5.1.5. Other Cancers

6.      Global Carmustine Market Estimates & Forecast Trend Analysis, by Distribution Channel

6.1.    Global Carmustine Market Revenue (US$ Mn) Estimates and Forecasts, by Distribution Channel, 2019 to 2034

6.1.1. Hospital Pharmacies

6.1.2. Retail Pharmacies

6.1.3. Online Pharmacies

7.      Global Carmustine Market Estimates & Forecast Trend Analysis, by Region

7.1.    Global Carmustine Market Revenue (US$ Mn) Estimates and Forecasts, by Region, 2019 to 2034

7.1.1. North America

7.1.2. Europe

7.1.3. Asia Pacific

7.1.4. Middle East & Africa

7.1.5. South America

8.      North America Carmustine Market: Estimates & Forecast Trend Analysis

8.1.    North America Carmustine Market Assessments & Key Findings

8.1.1. North America Carmustine Market Introduction

8.1.2. North America Carmustine Market Size Estimates and Forecast (US$ Million) (2019 – 2034)

8.1.2.1.   By Product Type

8.1.2.2.   By Application

8.1.2.3.   By Distribution Channel

8.1.2.4.   By Country

8.1.2.4.1.     The U.S.

8.1.2.4.2.     Canada

8.1.2.4.3.     Mexico

9.      Europe Carmustine Market: Estimates & Forecast Trend Analysis

9.1.    Europe Carmustine Market Assessments & Key Findings

9.1.1. Europe Carmustine Market Introduction

9.1.2. Europe Carmustine Market Size Estimates and Forecast (US$ Million) (2019 – 2034)

9.1.2.1.   By Product Type

9.1.2.2.   By Application

9.1.2.3.   By Distribution Channel

9.1.2.4.        By Country

9.1.2.4.1.     Germany

9.1.2.4.2.     U.K.

9.1.2.4.3.     France

9.1.2.4.4.     Italy

9.1.2.4.5.     Spain

9.1.2.4.6.     Russia

9.1.2.4.7.     Rest of Europe

10.  Asia Pacific Carmustine Market: Estimates & Forecast Trend Analysis

10.1.  Asia Pacific Market Assessments & Key Findings

10.1.1.   Asia Pacific Carmustine Market Introduction

10.1.2.   Asia Pacific Carmustine Market Size Estimates and Forecast (US$ Million) (2019 – 2034)

10.1.2.1.    By Product Type

10.1.2.2.    By Application

10.1.2.3.    By Distribution Channel

10.1.2.4.    By Country

10.1.2.4.1. China

10.1.2.4.2. Japan

10.1.2.4.3. India

10.1.2.4.4. Australia

10.1.2.4.5. South Korea

10.1.2.4.6. ASEAN

10.1.2.4.7. Rest of Asia Pacific

11.  Middle East & Africa Carmustine Market: Estimates & Forecast Trend Analysis

11.1.  Middle East & Africa Market Assessments & Key Findings

11.1.1.   Middle East & Africa Carmustine Market Introduction

11.1.2.   Middle East & Africa Carmustine Market Size Estimates and Forecast (US$ Million) (2019 – 2034)

11.1.2.1.    By Product Type

11.1.2.2.    By Application

11.1.2.3.    By Distribution Channel

11.1.2.4.    By Country

11.1.2.4.1. U.A.E.

11.1.2.4.2. Saudi Arabia

11.1.2.4.3. Egypt

11.1.2.4.4. South Africa

11.1.2.4.5. Rest of Middle East & Africa

12.  South America Carmustine Market: Estimates & Forecast Trend Analysis

12.1.  South America Market Assessments & Key Findings

12.1.1.   South America Carmustine Market Introduction

12.1.2.   South America Carmustine Market Size Estimates and Forecast (US$ Million) (2019 – 2034)

12.1.2.1.    By Product Type

12.1.2.2.    By Application

12.1.2.3.    By Distribution Channel

12.1.2.4.    By Country

12.1.2.4.1. Brazil

12.1.2.4.2. Argentina

12.1.2.4.3. Colombia

12.1.2.4.4. Rest of South America

13.  Competition Landscape

13.1.  Global Carmustine Market Competition Matrix & Benchmarking, by Leading Players / Innovators / Emerging Players / New Entrants

13.2.  Global Carmustine Market Competition White Space Analysis, By End-user

13.3.  Global Carmustine Market Competition Heat Map Analysis, By End-user

13.4.  Global Carmustine Market Concentration & Company Market Shares (%) Analysis, 2022

14.  Company Profiles

14.1.                     Hebei Meitu Pharmaceutical.

14.1.1.   Company Overview & Key Stats

14.1.2.   Financial Performance & KPIs

14.1.3.   Product Portfolio

14.1.4.   Business Strategy & Recent Developments

* Similar details would be provided for all the players mentioned below 

14.2.      Avet Pharmaceuticals Inc.

14.3.      Bristol Myers Squibb

14.4.      Accord Healthcare

14.5.      Amneal

14.6.      Emcure Pharma

14.7.      Marcan Pharmaceuticals

14.8.      Others

15.  Research Methodology

15.1.  External Transportations / Databases

15.2.  Internal Proprietary Database

15.3.  Primary Research

15.4.  Secondary Research

15.5.  Assumptions

15.6.  Limitations

15.7.  Report FAQs

16.  Research Findings & Conclusion